JP2013543501A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543501A5 JP2013543501A5 JP2013532213A JP2013532213A JP2013543501A5 JP 2013543501 A5 JP2013543501 A5 JP 2013543501A5 JP 2013532213 A JP2013532213 A JP 2013532213A JP 2013532213 A JP2013532213 A JP 2013532213A JP 2013543501 A5 JP2013543501 A5 JP 2013543501A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- seq
- patient
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39138810P | 2010-10-08 | 2010-10-08 | |
| US61/391,388 | 2010-10-08 | ||
| PCT/EP2011/067522 WO2012045848A1 (en) | 2010-10-08 | 2011-10-07 | Methods of treating psoriasis using il-17 antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013253745A Division JP2014114288A (ja) | 2010-10-08 | 2013-12-09 | Ｉｌ−１７アンタゴニストを用いて乾癬を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013543501A JP2013543501A (ja) | 2013-12-05 |
| JP2013543501A5 true JP2013543501A5 (enExample) | 2014-03-27 |
| JP5537740B2 JP5537740B2 (ja) | 2014-07-02 |
Family
ID=44759699
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013532213A Active JP5537740B2 (ja) | 2010-10-08 | 2011-10-07 | Ｉｌ−１７アンタゴニストを用いて乾癬を治療する方法 |
| JP2013253745A Withdrawn JP2014114288A (ja) | 2010-10-08 | 2013-12-09 | Ｉｌ−１７アンタゴニストを用いて乾癬を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013253745A Withdrawn JP2014114288A (ja) | 2010-10-08 | 2013-12-09 | Ｉｌ−１７アンタゴニストを用いて乾癬を治療する方法 |
Country Status (28)
| Country | Link |
|---|---|
| US (9) | US9717791B2 (enExample) |
| EP (5) | EP3299390A1 (enExample) |
| JP (2) | JP5537740B2 (enExample) |
| KR (3) | KR20150018595A (enExample) |
| CN (2) | CN107029234A (enExample) |
| AU (1) | AU2011311482B2 (enExample) |
| BR (1) | BR112013008501A2 (enExample) |
| CA (1) | CA2813900C (enExample) |
| CL (1) | CL2013000930A1 (enExample) |
| CY (1) | CY1119942T1 (enExample) |
| DK (1) | DK2625199T3 (enExample) |
| ES (1) | ES2660770T3 (enExample) |
| HK (1) | HK1247932A1 (enExample) |
| HR (1) | HRP20180301T1 (enExample) |
| HU (1) | HUE038334T2 (enExample) |
| IL (1) | IL225310A (enExample) |
| LT (1) | LT2625199T (enExample) |
| MA (1) | MA34646B1 (enExample) |
| MX (1) | MX356279B (enExample) |
| NO (1) | NO2625199T3 (enExample) |
| PH (1) | PH12013500660B1 (enExample) |
| PL (1) | PL2625199T3 (enExample) |
| PT (1) | PT2625199T (enExample) |
| RU (2) | RU2591083C2 (enExample) |
| SG (1) | SG188979A1 (enExample) |
| SI (1) | SI2625199T1 (enExample) |
| TW (2) | TWI564022B (enExample) |
| WO (1) | WO2012045848A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7833527B2 (en) | 2006-10-02 | 2010-11-16 | Amgen Inc. | Methods of treating psoriasis using IL-17 Receptor A antibodies |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| EA031209B9 (ru) | 2010-01-15 | 2021-11-19 | Кирин-Эмджен, Инк. | Фармацевтический состав антитела для лечения воспалительного заболевания и способы его применения |
| AU2011254557B2 (en) | 2010-05-20 | 2015-09-03 | Ablynx Nv | Biological materials related to HER3 |
| PT2625199T (pt) | 2010-10-08 | 2018-02-28 | Novartis Ag | Métodos de tratamento de psoríase usando antagonistas de il-17 |
| BR112013011176A2 (pt) | 2010-11-05 | 2020-09-01 | Novartis Ag | métodos de tratamento de artrite reumatoide usando antagonistas de il-17 |
| UA117218C2 (uk) | 2011-05-05 | 2018-07-10 | Мерк Патент Гмбх | Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f |
| AU2012341081B2 (en) * | 2011-11-21 | 2015-06-04 | Novartis Ag | Methods of treating psoriatic arthritis (PsA) using IL-17 antagonists and PsA response or non- response alleles |
| EP3689369A1 (en) * | 2013-03-15 | 2020-08-05 | Amgen, Inc | Methods for treating psoriasis using an anti-il-23 antibody |
| WO2014143540A1 (en) * | 2013-03-15 | 2014-09-18 | Amgen Inc. | Methods for treating crohn's disease using an anti-il23 antibody |
| US10434172B2 (en) | 2013-08-15 | 2019-10-08 | Novartis Ag | Methods of treating generalized pustular psoriasis (GPP) using IL-17 antagonists |
| KR101836756B1 (ko) | 2013-12-27 | 2018-03-08 | 오사카 유니버시티 | Il-17a를 표적화하는 백신 |
| RU2577228C2 (ru) * | 2014-03-14 | 2016-03-10 | Закрытое Акционерное Общество "Биокад" | Анти-il-17-антитела, способ их получения и способ применения |
| MY184189A (en) * | 2014-03-31 | 2021-03-24 | Amgen K A Inc | Methods of treating nail and scalp psoriasis |
| CA2949236C (en) | 2014-05-15 | 2023-06-13 | Incube Labs, Llc | Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins |
| US11548940B2 (en) | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| WO2016031250A1 (en) * | 2014-08-26 | 2016-03-03 | Kirin-Amgen, Inc. | Method for treating psoriasis patient which received anti-tnf-alpha antibody therapy |
| SMT202400285T1 (it) * | 2014-09-10 | 2024-09-16 | Novartis Ag | Uso di antagonisti di il-17 per inibire la progressione del danno strutturale in pazienti affetti da artrite psoriasica |
| AR103172A1 (es) * | 2014-12-22 | 2017-04-19 | Novartis Ag | Reducción selectiva de residuos de cisteina en anticuerpos il-17 |
| AR103173A1 (es) | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| CA2978431C (en) | 2015-03-02 | 2023-10-24 | 180 Therapeutics Lp | Method of treating a localized fibrotic disorder using a tnf receptor 2 antagonist |
| EP3167892A1 (en) | 2015-11-10 | 2017-05-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for preventing or treating imflammatory bowel diseases |
| RU2754683C2 (ru) * | 2015-10-27 | 2021-09-06 | Юсб Биофарма Срл | Способы лечения с использованием анти-il-17a антител |
| WO2018015880A1 (en) | 2016-07-19 | 2018-01-25 | Novartis Ag | Methods of treating new-onset plaque type psoriasis using il-17 antagonists |
| WO2018096467A1 (en) * | 2016-11-28 | 2018-05-31 | Novartis Ag | Methods of treating acne using interleukin-17 (il-17) antagonists |
| WO2018158741A1 (en) * | 2017-03-03 | 2018-09-07 | Novartis Ag | Psoriasis disease modification following long-term treatment with an il-17 antagonist |
| EP3672988A1 (en) * | 2017-08-23 | 2020-07-01 | Eli Lilly and Company | Treatment of genital psoriasis |
| TWI808397B (zh) * | 2018-09-11 | 2023-07-11 | 美商美國禮來大藥廠 | 治療牛皮癬之方法 |
| EP4006053A4 (en) | 2019-07-30 | 2022-10-26 | Jiangsu Hengrui Medicine Co., Ltd. | METHOD OF TREATMENT OF AUTOIMMUNE DISEASE BY IL-17 ANTAGONISTS |
| BR112022004941A2 (pt) | 2019-09-20 | 2022-06-28 | Novartis Ag | Métodos para tratar doenças autoimunes com o uso de antagonistas de interleucina-17 (il-17) |
| WO2022127842A1 (zh) * | 2020-12-17 | 2022-06-23 | 上海华奥泰生物药业股份有限公司 | 靶向il-17a和il-36r的双特异性抗体及其应用 |
| TW202246329A (zh) * | 2021-03-03 | 2022-12-01 | 大陸商蘇州盛迪亞生物醫藥有限公司 | 抗il-17抗體治療自體免疫性疾病和炎症的方法 |
| WO2023186174A1 (en) * | 2022-04-01 | 2023-10-05 | Zai Lab (Shanghai) Co., Ltd. | Topical formulation comprising an il-17a binding molecule and uses thereof |
| CN116593718B (zh) * | 2023-07-18 | 2023-09-15 | 军科正源（北京）药物研究有限责任公司 | 用于检测司库奇尤单抗抗药性抗体的试剂 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5250442A (en) | 1993-04-08 | 1993-10-05 | Orestes Cabezas | Method of treating rheumatoid arthritis using tetracycline |
| US6309636B1 (en) | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| GB9422306D0 (en) * | 1994-11-04 | 1994-12-21 | Sandoz Ltd | Organic compounds |
| US6093745A (en) * | 1997-11-25 | 2000-07-25 | Psorx, L.L.C. | Methods and composition for treating skin proliferative diseases |
| US20050147609A1 (en) | 1998-05-15 | 2005-07-07 | Genentech, Inc. | Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis |
| JP2000186046A (ja) | 1998-10-14 | 2000-07-04 | Snow Brand Milk Prod Co Ltd | 慢性関節リウマチ治療剤及び診断方法 |
| JP4159682B2 (ja) | 1998-12-22 | 2008-10-01 | 株式会社クラレ | 止血材 |
| WO2002032374A2 (en) * | 2000-10-18 | 2002-04-25 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| US20090280065A1 (en) * | 2006-04-10 | 2009-11-12 | Willian Mary K | Uses and Compositions for Treatment of Psoriasis |
| US8039642B2 (en) | 2003-12-09 | 2011-10-18 | Life Technologies Corporation | Pyrenyloxysulfonic acid fluorescent agents |
| TWI439284B (zh) * | 2004-04-09 | 2014-06-01 | Abbvie Biotechnology Ltd | 用於治療ＴＮＦα相關失調症之多重可變劑量療法 |
| GB0417487D0 (en) * | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| WO2006096461A2 (en) | 2005-03-08 | 2006-09-14 | Pharmacia & Upjohn Company Llc | Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent |
| EP2322219A3 (en) * | 2005-09-01 | 2013-06-05 | Merck Sharp & Dohme Corp. | Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
| MY149159A (en) | 2005-11-15 | 2013-07-31 | Hoffmann La Roche | Method for treating joint damage |
| LT2481753T (lt) * | 2005-12-13 | 2018-05-25 | Eli Lilly And Company | Anti-il-17 antikūnai |
| RU2430110C2 (ru) | 2006-01-31 | 2011-09-27 | Новартис Аг | Антитела - антагонисты интерлейкина-17 (ил-17) для лечения рака |
| TW200815469A (en) | 2006-06-23 | 2008-04-01 | Astrazeneca Ab | Compounds |
| EA200970250A1 (ru) | 2006-09-05 | 2010-02-26 | Медарекс, Инк. | Антитела к костным морфогенетическим белкам и их рецепторам и способы их применения |
| US7833527B2 (en) | 2006-10-02 | 2010-11-16 | Amgen Inc. | Methods of treating psoriasis using IL-17 Receptor A antibodies |
| RU2367429C2 (ru) | 2007-01-30 | 2009-09-20 | Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН | Способ лечения псориаза |
| AU2008232903B9 (en) | 2007-03-30 | 2013-09-05 | Medimmune Llc | Antibodies with decreased deamidation profiles |
| EP2152318A4 (en) * | 2007-06-01 | 2011-12-07 | Abbott Biotech Ltd | COMPOSITIONS AND USES FOR THE TREATMENT OF PSORIASIS AND CROHN'S DISEASE |
| CN101932935A (zh) | 2007-06-20 | 2010-12-29 | 先灵公司 | 用于炎性关节病抗白介素-17a治疗的关节破坏生物标记 |
| US7720605B2 (en) | 2007-06-22 | 2010-05-18 | Weyerhaeuser Nr Company | Identifying vegetation attributes from LiDAR data |
| RU2341272C1 (ru) * | 2007-10-22 | 2008-12-20 | Левон Никитович Мкртчян | Средство для неспецифической иммунотерапии |
| JP2011523853A (ja) | 2008-06-03 | 2011-08-25 | アボット・ラボラトリーズ | 二重可変ドメイン免疫グロブリン及びその使用 |
| US20090301682A1 (en) | 2008-06-05 | 2009-12-10 | Baker Hughes Incorporated | Casting furnace method and apparatus |
| BRPI0915448A2 (pt) | 2008-07-08 | 2015-11-10 | Abbott Lab | imunoglobulinas de domínio variável duplo para prostaglandina e2 e usos das mesmas |
| KR101318549B1 (ko) * | 2008-09-29 | 2013-10-16 | 로슈 글리카트 아게 | 인간 ｉｌ17 에 대한 항체 및 이의 용도 |
| BRPI0921845A2 (pt) | 2008-11-12 | 2019-09-17 | Medimmune Llc | formulação aquosa estéril estável, forma de dosagem unitária farmacêutica, seringa pré-carregada, e, métodos para tratar uma doença ou distúrbio, para tratar ou prevenir rejeição, para esgotar células t que expressam icos em um paciente humano, e para interromper arquitetura central germinal em um órgão linfóide secundário de um primata |
| US20110256130A1 (en) | 2008-12-01 | 2011-10-20 | Joshua Robert Schultz | Methods of treating inflammatory disorders |
| SG173705A1 (en) | 2009-03-05 | 2011-09-29 | Abbott Lab | Il-17 binding proteins |
| PT2625199T (pt) | 2010-10-08 | 2018-02-28 | Novartis Ag | Métodos de tratamento de psoríase usando antagonistas de il-17 |
| BR112013011176A2 (pt) | 2010-11-05 | 2020-09-01 | Novartis Ag | métodos de tratamento de artrite reumatoide usando antagonistas de il-17 |
| AR084234A1 (es) | 2010-12-13 | 2013-05-02 | Novartis Ag | Metodos predictivos y metodos para tratar artritis usando antagonistas de interleuquina 17 (il-17) |
| AU2012341081B2 (en) | 2011-11-21 | 2015-06-04 | Novartis Ag | Methods of treating psoriatic arthritis (PsA) using IL-17 antagonists and PsA response or non- response alleles |
| JP2015519311A (ja) | 2012-04-20 | 2015-07-09 | ノバルティス アーゲー | Ｉｌ−１７アンタゴニストを用いて強直性脊椎炎を治療する方法 |
| WO2014155278A2 (en) | 2013-03-26 | 2014-10-02 | Novartis Ag | Methods of treating autoimmune diseases using il-17 antagonists |
| AR103173A1 (es) | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| IL257723B2 (en) | 2015-10-19 | 2023-04-01 | Novartis Ag | Methods for the treatment of non-radiographic sclerosing spondylitis with the help of interleukin-17 (il-17) antagonists |
| US11280479B2 (en) | 2017-10-18 | 2022-03-22 | The Sloan Company | Sign box light module |
-
2011
- 2011-10-07 PT PT117647644T patent/PT2625199T/pt unknown
- 2011-10-07 HR HRP20180301TT patent/HRP20180301T1/hr unknown
- 2011-10-07 CN CN201710261381.2A patent/CN107029234A/zh active Pending
- 2011-10-07 RU RU2013120957/15A patent/RU2591083C2/ru active
- 2011-10-07 EP EP17195148.6A patent/EP3299390A1/en not_active Withdrawn
- 2011-10-07 CN CN2011800487322A patent/CN103154031A/zh active Pending
- 2011-10-07 CA CA2813900A patent/CA2813900C/en active Active
- 2011-10-07 TW TW105116323A patent/TWI564022B/zh active
- 2011-10-07 KR KR1020147036815A patent/KR20150018595A/ko not_active Withdrawn
- 2011-10-07 KR KR1020147018691A patent/KR101620771B1/ko active Active
- 2011-10-07 DK DK11764764.4T patent/DK2625199T3/en active
- 2011-10-07 KR KR1020137011792A patent/KR20130110179A/ko not_active Ceased
- 2011-10-07 EP EP22186296.4A patent/EP4137514A1/en active Pending
- 2011-10-07 HU HUE11764764A patent/HUE038334T2/hu unknown
- 2011-10-07 US US13/876,367 patent/US9717791B2/en active Active
- 2011-10-07 ES ES11764764.4T patent/ES2660770T3/es active Active
- 2011-10-07 PH PH1/2013/500660A patent/PH12013500660B1/en unknown
- 2011-10-07 EP EP25216056.9A patent/EP4670788A3/en active Pending
- 2011-10-07 BR BR112013008501A patent/BR112013008501A2/pt active Search and Examination
- 2011-10-07 SG SG2013018486A patent/SG188979A1/en unknown
- 2011-10-07 SI SI201131408T patent/SI2625199T1/en unknown
- 2011-10-07 NO NO11764764A patent/NO2625199T3/no unknown
- 2011-10-07 EP EP11764764.4A patent/EP2625199B1/en active Active
- 2011-10-07 MX MX2013003916A patent/MX356279B/es active IP Right Grant
- 2011-10-07 RU RU2016120615A patent/RU2665954C1/ru active
- 2011-10-07 LT LTEP11764764.4T patent/LT2625199T/lt unknown
- 2011-10-07 AU AU2011311482A patent/AU2011311482B2/en active Active
- 2011-10-07 JP JP2013532213A patent/JP5537740B2/ja active Active
- 2011-10-07 IL IL225310A patent/IL225310A/en active IP Right Grant
- 2011-10-07 EP EP20187002.9A patent/EP3792281A1/en not_active Ceased
- 2011-10-07 WO PCT/EP2011/067522 patent/WO2012045848A1/en not_active Ceased
- 2011-10-07 PL PL11764764T patent/PL2625199T3/pl unknown
- 2011-10-07 TW TW100136608A patent/TWI548419B/zh active
-
2013
- 2013-04-05 CL CL2013000930A patent/CL2013000930A1/es unknown
- 2013-05-03 MA MA35872A patent/MA34646B1/fr unknown
- 2013-12-09 JP JP2013253745A patent/JP2014114288A/ja not_active Withdrawn
-
2017
- 2017-06-22 US US15/630,577 patent/US10583190B2/en active Active
-
2018
- 2018-02-22 CY CY20181100220T patent/CY1119942T1/el unknown
- 2018-06-01 HK HK18107225.2A patent/HK1247932A1/en unknown
-
2019
- 2019-12-19 US US16/720,351 patent/US11534490B2/en active Active
-
2020
- 2020-12-18 US US17/127,738 patent/US20210113688A1/en not_active Abandoned
-
2021
- 2021-02-02 US US17/165,724 patent/US20210162044A1/en not_active Abandoned
-
2022
- 2022-12-02 US US18/061,227 patent/US20230321231A1/en active Pending
-
2024
- 2024-12-16 US US18/983,037 patent/US20250161445A1/en active Pending
- 2024-12-16 US US18/983,034 patent/US20250161444A1/en active Pending
- 2024-12-16 US US18/983,030 patent/US12551554B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013543501A5 (enExample) | ||
| JP2014114288A5 (enExample) | ||
| US11167004B2 (en) | Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor | |
| RU2013120957A (ru) | Способы лечения псориаза с использованием антагонистов il-17 | |
| CN112153982A (zh) | 用于通过施用il-4r抑制剂治疗特应性皮炎的方法 | |
| EA014025B1 (ru) | Композиции антитела против cd3 | |
| JP2008535841A5 (enExample) | ||
| JP2016065094A5 (enExample) | ||
| JP2018515493A5 (enExample) | ||
| RU2016136364A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| JP2014515763A5 (enExample) | ||
| US20220110999A1 (en) | Methods for treating severe atopic dermatitis by administering an il-4r inhibitor | |
| JP2016520082A5 (enExample) | ||
| JP2016514132A5 (enExample) | ||
| JP2015530867A5 (enExample) | ||
| KR20220158821A (ko) | Il-4r 길항제를 투여함에 의해 아토피 피부염을 치료하기 위한 방법 | |
| JP2020502219A5 (enExample) | ||
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| CN105251004A (zh) | 在诊断和治疗类风湿性关节炎中使用的包含抗-cd6单克隆抗体的药物组合物 | |
| CN101878037A (zh) | 能够中和乙型肝炎病毒的人抗体在预防或治疗乙型肝炎病毒感染中的用途 | |
| JP2020100653A (ja) | ベンラリツマブによる喘息症状の改善方法 | |
| JP2019519584A5 (enExample) | ||
| BR112020017445A2 (pt) | anticorpos anti cd6 para tratar asma severa | |
| US20230265168A1 (en) | Antibody binding to hepatitis b virus surface antigen and application of antibody | |
| RU2020111574A (ru) | Высококонцентрированные, маловязкие препараты ингибирующих masp-2 антител, наборы и способы лечения субъектов, страдающих атипическим гемолитическим синдромом |